Prognostic value of hematological parameters in older adult patients with acute coronary syndrome undergoing coronary

Umar Hafiz Khan1, Murtaza Rashid Pala2, Imran Hafeez3

  • 1Geriatric Medicine, Department of Internal Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.

PubMed

Insights

Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can predict 30-day mortality in elderly patients with acute coronary syndrome (ACS). NLR is a more reliable predictor than total white blood cell count for risk classification.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Hematology

Background:

  • Cardiovascular disease (CVD) significantly impacts geriatric patients.
  • Systemic inflammation is linked to age-related bone marrow changes and atherosclerosis.
  • Hematological biomarkers may predict mortality in elderly ACS patients.

Purpose of the Study:

  • To evaluate the predictive accuracy of hematological biomarkers for 30-day mortality in older adults with acute coronary syndrome (ACS).

Main Methods:

  • Prospective observational study of 601 elderly ACS patients (age > 60) undergoing percutaneous coronary intervention.
  • Assessed baseline hematological parameters and 30-day mortality.
  • Utilized logistic regression and receiver operating characteristic (ROC) curve analysis.

Main Results:

  • Mean age was 77 years. Mean NLR was 5.07; mean PLR was 108.65.
  • Univariate analysis showed NLR (OR=1.10) and PLR (OR=1.05) associated with mortality.
  • NLR predicted mortality with 68.1% accuracy; PLR with 65.7% accuracy. NLR was an independent predictor (OR=1.096).

Conclusions:

  • Neutrophil-lymphocyte ratio (NLR) is a valuable predictor of 30-day mortality in elderly ACS patients.
  • NLR demonstrates higher predictive accuracy compared to total white blood cell count.
  • NLR is recommended for risk stratification in geriatric ACS patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
200
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
118
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11